NFKB1 and breast carcinoma: Our results provide new useful insights into the effect of the different compounds on NF-κB transcriptional down regulation in human breast cancer cells and open new possibilities to investigate NF-κB signaling in other established human cancer cell lines by implementing the triple colored bioluminescent reporter cell system.